Published on: December 30, 2014
by Megan Brooks for Medscape:
The FDA has approved a combination pill for moderate to severe Alzheimer’s disease in people already being treated with both drugs.
The pill, called Namzaric, combines memantine hydrochloride extended-release (Namenda) and donepezil hydrochloride (Aricept).
The two drugs are often prescribed together. About 70% of people on Namenda XR are also on Aricept, says David Nicholson, PhD, in a statement. He’s the senior vice president of global brands R&D for drugmaker Actavis.
“Both Namenda XR and donepezil have proven efficacy and safety for the treatment of moderate to severe Alzheimer’s disease,” Nicholson says. Also, research shows that people who took the combo pill showed greater improvement overall, and with thinking, than those on donepezil alone, he says.
Namzaric is a capsule that’s taken once a day. The capsules can be opened and sprinkled on food for people who have trouble swallowing. The drug will be available in two strengths.
Older people who report greater levels of social engagement have more robust gray matter in regions of the brain relevant in dementia, according to new research led by scientists at the University of Pittsburgh Graduate School of...
In a new study, University of Nebraska–Lincoln sociologist Marc A. Garcia explored how educational attainment can benefit cognitive health in later life, and whether there are differences in its benefits among minorities. Garcia and his co-authors...
A genetic variation in some people may be associated with cognitive decline that can’t be explained by deposits of two key proteins associated with Alzheimer’s disease, amyloid β and tau, according to a study...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.